Patent Owner's Unopposed Motion for Pro Hac Vice Admission of Han Xu | Dec 24, 2025 | PAPER | PATENT OWNER |
EX2028 - Declaration of Han Xu | Dec 24, 2025 | EXHIBIT | PATENT OWNER |
Patent Owner's Unopposed Motion for Pro Hac Vice Admission of Hayley R. LeBlanc | Dec 24, 2025 | PAPER | PATENT OWNER |
EX2029 - Declaration of Hayley R. LeBlanc | Dec 24, 2025 | EXHIBIT | PATENT OWNER |
Patent Owner's Supplemental Mandatory Notice | Dec 23, 2025 | PAPER | PATENT OWNER |
Patent Owner's Unopposed Motion for Pro Hac Vice Admission of Jacob M. Berman | Dec 23, 2025 | PAPER | PATENT OWNER |
EX2027 - Declaration of Jacob M. Berman | Dec 23, 2025 | EXHIBIT | PATENT OWNER |
Notice of Deposition of Jason McConville, Ph.D. | Dec 22, 2025 | PAPER | PATENT OWNER |
Notice of Deposition of Ron Bihovsky, Ph.D. | Dec 22, 2025 | PAPER | PATENT OWNER |
Petitioner's Opposition to Patent Owner's Motion for Discovery | Dec 16, 2025 | PAPER | PETITIONER |
Patent Owner's Motion to Seal | Dec 8, 2025 | PAPER | PATENT OWNER |
Patent Owner's Motion for Additional Discovery (SEALED) | Dec 8, 2025 | PAPER | PATENT OWNER |
Corrected Patent Owner's Motion for Additional Discovery (SEALED) | Dec 8, 2025 | PAPER | PATENT OWNER |
Patent Owner's Motion for Additional Discovery (REDACTED) | Dec 8, 2025 | PAPER | PATENT OWNER |
EX2024 - December 6, 2025 Collection of Email Communications with Intas’s Counsel | Dec 8, 2025 | EXHIBIT | PATENT OWNER |
EX2025 - Declaration of Sayem Osman | Dec 8, 2025 | EXHIBIT | PATENT OWNER |
EX2026 - U.S. Patent No. 12,245,997 | Dec 8, 2025 | EXHIBIT | PATENT OWNER |
Order: Authorizing Additional Discovery | Nov 26, 2025 | PAPER | BOARD |
Patent Owner Atossa's Objections to Evidence | Nov 18, 2025 | PAPER | PATENT OWNER |
Institution Decision: Grant | Nov 3, 2025 | PAPER | BOARD |
Order: Scheduling Order | Nov 3, 2025 | PAPER | BOARD |
Director Discretionary Decision: Refer | Aug 29, 2025 | PAPER | BOARD |
Patent Owner's Authorized Reply to Petitioner's Response to Patent Owner's Request for Discretionary Denial | Aug 26, 2025 | PAPER | PATENT OWNER |
EX2023 - Corrected Covenant Not to Sue | Aug 26, 2025 | EXHIBIT | PATENT OWNER |
Email Correspondence | Aug 22, 2025 | EXHIBIT | BOARD |
Petitioner's Response to Patent Owner's Request for Discretionary Denial of Institution | Aug 7, 2025 | PAPER | PETITIONER |
Chen P. et al. (2018) | Aug 7, 2025 | EXHIBIT | PETITIONER |
Goetz MP et al. (2017) | Aug 7, 2025 | EXHIBIT | PETITIONER |
Takebe N et al. (2021) | Aug 7, 2025 | EXHIBIT | PETITIONER |
Patent Owner's Preliminary Response | Aug 5, 2025 | PAPER | PATENT OWNER |
EX2001 - ATOSSA THERAPEUTICS, INC. QUARTERLY REPORT FORM 10-Q for the Quarterly Period Ended March 31, 2025 | Jul 7, 2025 | EXHIBIT | PATENT OWNER |
EX2002 - Atossa Therapeutics Proposes Potentially Groundbreaking Study Aimed at Reducing Interval Breast Cancer in High-Risk Women at AACR 2025 (April 29, 2025) | Jul 7, 2025 | EXHIBIT | PATENT OWNER |
EX2003 - Atossa Therapeutics Announces Plans to Pursue Metastatic Breast Cancer Indication for (Z)-Endoxifen and Continued Engagement with FDA on Additional Indications (March 11, 2025) | Jul 7, 2025 | EXHIBIT | PATENT OWNER |
EX2004 - Financials – Intas Pharmaceuticals Ltd. | Jul 7, 2025 | EXHIBIT | PATENT OWNER |
EX2005 - Atossa Therapeutics Announces Issuance of Key U.S. Patent Covering Endoxifen (March 8, 2022) | Jul 7, 2025 | EXHIBIT | PATENT OWNER |
EX2006 - Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients, NCT06608641 (Last Updated March 17, 2025) | Jul 7, 2025 | EXHIBIT | PATENT OWNER |
EX2008 - Atossa Covenant Not to Sue | Jul 7, 2025 | EXHIBIT | PATENT OWNER |
EX2009 - Atossa Therapeutics Announces Full Results from Phase 2 KARISMA-Endoxifen Study Demonstrating Statistically Significant Reductions in Mammographic Breast Density (Dec. 11, 2024) | Jul 7, 2025 | EXHIBIT | PATENT OWNER |
EX2010 - Atossa Therapeutics Announces First Quarter 2025 Financial Results and Provides a Corporate Update (May 13, 2025) | Jul 7, 2025 | EXHIBIT | PATENT OWNER |
EX2012 - Breast Center Year in Review, An Unmet Need in HR-Positive Endocrine-Resistant Breast Cancer | Jul 7, 2025 | EXHIBIT | PATENT OWNER |
EX2013 - ATOSSA THERAPEUTICS, INC. ANNUAL REPORT FORM 10-K for the Fiscal Year Ended December 31, 2024 | Jul 7, 2025 | EXHIBIT | PATENT OWNER |
EX2015 - Intas Requirements For Resolving Disputes With Atossa (FILED UNDER SEAL) | Jul 7, 2025 | EXHIBIT | PATENT OWNER |
EX2016 - Default Protective Order | Jul 7, 2025 | EXHIBIT | PATENT OWNER |
EX2017 - Intas Pharmaceuticals, Limited v. Atossa Therapeutics, Inc., IPR2025-00799, Pap.2 (Apr. 3, 2025) | Jul 7, 2025 | EXHIBIT | PATENT OWNER |
EX2018 - Intas Pharmaceuticals, Limited v. Atossa Therapeutics, Inc., PGR2023-00043, Pap.1 (Aug. 18, 2023) | Jul 7, 2025 | EXHIBIT | PATENT OWNER |
EX2019 - Rishab Gupta & Swarndeep Singh, Endoxifen Approval for Bipolar in India, A Premature or a Pragmatic Decision?, 43(1) J. CLINICAL PSYCHOPHARMACOLOGY 3 (2023) | Jul 7, 2025 | EXHIBIT | PATENT OWNER |
EX2020 - Zonalta, Why Zonalta? | Jul 7, 2025 | EXHIBIT | PATENT OWNER |
EX2021 - Atossa Therapeutics Granted Additional Patent Protection for Endoxifen (August 28, 2024) | Jul 7, 2025 | EXHIBIT | PATENT OWNER |
EX2022 - Declaration of Megan Raymond | Jul 7, 2025 | EXHIBIT | PATENT OWNER |
EX2007 - Declaration of Sayem Osman | Jul 7, 2025 | EXHIBIT | PATENT OWNER |
EX2014 - U.S. Patent No. 11,572,334 | Jul 7, 2025 | EXHIBIT | PATENT OWNER |
Patent Owner's Motion to Seal | Jul 7, 2025 | PAPER | PATENT OWNER |
Patent Owner's Discretionary Denial Request [FILED UNDER SEAL] | Jul 7, 2025 | PAPER | PATENT OWNER |
Patent Owner's Discretionary Denial Request [REDACTED] | Jul 7, 2025 | PAPER | PATENT OWNER |
Notice: Notice filing date accorded | May 5, 2025 | PAPER | BOARD |
Power of Attorney and Designation of Lead Back-Up Counsel | Apr 17, 2025 | PAPER | PATENT OWNER |
Patent Owner's Mandatory Notices | Apr 17, 2025 | PAPER | PATENT OWNER |
USPN 12,071,391 | Apr 3, 2025 | EXHIBIT | PETITIONER |
File history of USPN 12,071,391 | Apr 3, 2025 | EXHIBIT | PETITIONER |
9,333,190 (Ahmad) | Apr 3, 2025 | EXHIBIT | PETITIONER |
WO2017/70651 (Liu) | Apr 3, 2025 | EXHIBIT | PETITIONER |
Excerpt of Handbook of Pharmaceutical Salts | Apr 3, 2025 | EXHIBIT | PETITIONER |
Benameur | Apr 3, 2025 | EXHIBIT | PETITIONER |
de Villiers | Apr 3, 2025 | EXHIBIT | PETITIONER |
Stegemann | Apr 3, 2025 | EXHIBIT | PETITIONER |
Excerpts of Handbook of Pharmaceutical Excipients | Apr 3, 2025 | EXHIBIT | PETITIONER |
Cole | Apr 3, 2025 | EXHIBIT | PETITIONER |
Ahmad (2010) | Apr 3, 2025 | EXHIBIT | PETITIONER |
Ahmad (2012) | Apr 3, 2025 | EXHIBIT | PETITIONER |
Fauq (2010) | Apr 3, 2025 | EXHIBIT | PETITIONER |
Milroy | Apr 3, 2025 | EXHIBIT | PETITIONER |
Krahn | Apr 3, 2025 | EXHIBIT | PETITIONER |
A Focus on Crystallography | Apr 3, 2025 | EXHIBIT | PETITIONER |
Fan | Apr 3, 2025 | EXHIBIT | PETITIONER |
Urso | Apr 3, 2025 | EXHIBIT | PETITIONER |
Endoxifen | Apr 3, 2025 | EXHIBIT | PETITIONER |
Ansel - capsules | Apr 3, 2025 | EXHIBIT | PETITIONER |
Beasley | Apr 3, 2025 | EXHIBIT | PETITIONER |
WO2011/107855 (Gandhi) | Apr 3, 2025 | EXHIBIT | PETITIONER |
11,572,334 | Apr 3, 2025 | EXHIBIT | PETITIONER |
Supporting Information to Milroy | Apr 3, 2025 | EXHIBIT | PETITIONER |
Ali | Apr 3, 2025 | EXHIBIT | PETITIONER |
Supporting Information to Fauq | Apr 3, 2025 | EXHIBIT | PETITIONER |
Elkins | Apr 3, 2025 | EXHIBIT | PETITIONER |
Reid | Apr 3, 2025 | EXHIBIT | PETITIONER |
Shargel | Apr 3, 2025 | EXHIBIT | PETITIONER |
Ansel | Apr 3, 2025 | EXHIBIT | PETITIONER |
Wieckhusen | Apr 3, 2025 | EXHIBIT | PETITIONER |
Richardson | Apr 3, 2025 | EXHIBIT | PETITIONER |
Expert Declaration of Jason McConville, Ph.D. | Apr 3, 2025 | EXHIBIT | PETITIONER |
Expert Declaration of Ron Bihovsky, Ph.D. | Apr 3, 2025 | EXHIBIT | PETITIONER |
Notice: Power of Attorney | Apr 3, 2025 | PAPER | PETITIONER |
Petition: as filed | Apr 3, 2025 | PAPER | PETITIONER |